From: CRISPR screening in hematology research: from bulk to single-cell level
 | Cell type | gRNA capture | Perturbation type | Cas | Number of gRNAs | gRNA multiplexing | Number of cells | Delivery | Sequencing chemistry | Readout |
---|---|---|---|---|---|---|---|---|---|---|
Transcriptomics | ||||||||||
CROP-seq [46] | Jurkat | Poly-A | CRISPRko | Cas9 | 119 | – | 5798 (+ 1320 cells with NT gRNA) | Lentiviral | DROP-seq | RNA |
K562 | Barcode | CRISPRi | dCas9-KRAB | UPR epistasis screen: 9 triplet combinations UPR Perturb-seq experiment: 91 | Up to 3 gRNAs in a single vector | UPR epistasis screen: 15006 UPR Perturb-seq experiment: 65337 | Lentiviral | 10X Genomics 3′-seq | RNA | |
BMDCs, K562 | Barcode | CRISPRko | Cas9 | BMDC: 67 K562: 46 + 36 | MIMOSCA can study interaction effects based on cells with multiple gRNAs | BMDC: 70000 K562: 104000 + 26000 | Lentiviral | 10X Genomics 3′-RNA-seq DROP-seq | RNA | |
CRISP-seq [45] | Bone marrow cells, LSK cells | Barcode | CRISPRko | Cas9 | Bone marrow: 57 In vivo: 5 genes + 2 control gRNAs | Multiplexing 2 gRNAs using 2 vectors with each a different fluorophore | Bone marrow: 6144 In vivo: 2768 | Lentiviral | MARS-seq | RNA |
Mosaic-seq [47] | K562 | Barcode | CRISPRi | dCas9-KRAB | 241 | High MOI | 12444 | Lentiviral | DROP-seq | RNA |
Direct-capture Perturb-seq [74] | K562, iPSCs | gRNA-specific primer, capture sequence | CRISPRko CRISPRi CRISPRa | Cas9 dCas9-KRAB-dCas9-SunTag/scFV-VP64 | K562 UPR screen: 32 iPSCs: 40 K562 interaction screen: 92 gRNA pairs K562 multiplexed screen: 87 CRISPRi, 49 CRISPRa gRNAs | gRNA pairs | K562 UPR screen: ~ 50000 iPSCs:5300 K562 interaction screen: ~ 30000 K562 multiplexed screen: ~ 30000 | Lentiviral | 10X Genomics 3′-seq with feature barcoding 10X Genomics 5′ seq | RNA |
TAP-seq [84] | K562 | Poly-A | CRISPRi | dCas9-KRAB | 7055 | – | 231667 | Lentiviral | 10X Genomics 3′-seq DROP-seq | RNA |
In vivo Perturb-seq [113] | Mouse embryo forebrain ventricles | Barcode | CRISPRko | Cas9 | 38 gRNA pairs | 2 gRNAs | 46770 | Lentiviral injection in the forebrain | 10X Genomics 3′-seq | RNA |
Genome-wide Perturb-seq [136] | K562, Rpe1 | Capture sequence | CRISPRi | dCas9-KRAB | 11294 (K562 all expressed genes) 2291 (K562 essential genes) 2688 (Rpe1 essential genes) | 2 gRNAs per vector | > 2.5 million cells | Lentiviral | 10X Genomics 3′-seq with feature barcoding | RNA |
Direct-seq [73] | HEK293T, Jurkat, K562 | 8A8G tag | CRISPRko, CRISPRa | Cas9 dCas9–VP64 MS2–p65–HSF1 | 12472 gRNA pairs | gRNA pairs | 13435 | Lentiviral | Fluidigm C1 10X Genomics 3′ and 5′-seq | RNA |
Sc-Tiling [106] | MLL-AF9 murine leukemic cells | Capture sequence | CRISPRko | Cas9 | 602 | – | 4943 | Lentiviral | 10X Genomics 3′-seq with feature barcoding | RNA |
Sc-eVIP* [111] | A549 lung cancer cells | Barcode | Coding variant overexpression | / | 100 TP53 variants 101 KRAS variants | – | 162314 (TP53) 150044 (KRAS) | Lentiviral | 10X Genomics 3′-seq | RNA |
POKI-seq [143] | Primary human T cells | Barcode | Custom HDR template | Cas9 | 36 knock-in templates | – |  > 40000 | Electroporation of Cas9 RNP with HDR templates | 10X Genomics 3′-seq | RNA |
Deaminase screening [108] | A375 | Poly-A | base editing | BE3 | 420 | – | 13218 | Lentiviral | Drop-seq | RNA |
Genga et al. [48] | human embryonic stem cells | Poly-A | CRISPRi | dCas9-KRAB | 160 | – | 16110 | Lentiviral | 10X Genomics 3′-seq | RNA |
Norman et al. [49] | K562 | Barcode | CRISPRa | dCas9-SunTag | 28680 gRNA pairs | Yes, dual-gRNA vector |  ~ 104000 | Lentiviral | 10X Genomics 3′-seq | RNA |
Tian et al. [50] | Human iPSC derived neurons | Poly-A | CRISPRi and CRISPRa | dCas9-KRAB DHFR-dCas9-VPH | CRISPRi: 374 CRISPRa: 206 | – | CRISPRi: ~ 58000 CRISPRa: ~ 38000 | Lentiviral | 10X Genomics 3′-seq | RNA |
Alda-Catalinas et al. [51] | Mouse embryonic stem cells | Poly-A | CRISPRa | dCas9-VP64 + MS2-p65-HSF1 | 475 | – | 203894 | Lentiviral | 10X Genomics 3′-seq | RNA |
Belk et al. [52] | OT-1T cells | gRNA-specific primer | CRISPRko | Cas9 | 48 | – | 70646 | Retroviral | 10X Genomics V(D)J 5′ scRNA with feature barcoding | RNA |
Giladi et al. [53] | LSK cells | Barcode | CRISPRko | Cas9 | 21 | – | 23641 | Lentiviral | MARS-seq | RNA |
DoNick-seq [54] | HEK293T, human intestinal crypt-like cells | Barcode | CRISPRko | Cas9 nickase | 16 × 4 | 2 gRNA pairs | 25602 | Lentiviral | 10X Genomics 3′-seq | RNA |
PerturbSci-Kinetics [140] | HEK293 | gRNA-specific primer | CRISPRi | dCas9-KRAB-MeCP2 | 699 | – | 161966 | Lentiviral | Combinatorial indexing | Nascent RNA |
Compressed perturb-seq [103] | THP-1 | Poly-A | CRISPRko CRISPRi | Cas9 dCas9-KRAB | 339 | Via overloading or high MOI | Cell-pooled: 32700 guide-pooled: 24192 | Lentiviral | 10X Genomics 3′-seq | RNA |
Proteomics | ||||||||||
Perturb-CITE-seq [132] | Melanoma cells cocultured with TILs | Poly-A | CRISPRko | Cas9 | 744 | – |  > 218000 | Lentiviral | 10X Genomics 3′-seq | RNA + protein |
ECCITE-seq [131] | PBMC, MyLa, Sez4, NIH/3T3, K562 | gRNA-specific primer | CRISPRko | Cas9 | Species mixing: 20 K562: 13 | – | Species mixing: 5935 K562: 4120 | Lentiviral | 10X Genomics 5′ V(D)J | RNA + protein + TCR/BCR |
Perturb-map [123] | KrasG12D p53−/− lung cancer cells, 4T1 | ProCode | CRISPRko | Cas9 | 101 | – | 8442439 | Lentiviral | 10X Genomics Visium | RNA + protein + imaging |
Rothenberg et al. [144] | LSK cells | Capture sequence | CRISPRko | Cas9 | 23 gRNA pairs | gRNA pairs |  ~ 5000 | Retroviral | 10X Genomics 3′-seq with feature barcoding | RNA + protein |
CaRPool-seq [104] | HEK293FT, THP1 | bcgRNA | RNA silencing | RfxCas13d | 29 crRNA arrays 385 crRNA arrays | CRISPR array processed by Cas13 | 9355 31308 | Lentiviral | 10X Genomics 3′-seq with feature barcoding | RNA + protein |
(bee)STING-seq [107] | K562 | gRNA-specific primer | CRISPRi CRISPR base editor | KRAB-dCas9-MeCP2 SpRY-Cas9-FNLS-BE3 | STING-seq: 1905 beeSTING-seq: 338 | – | STING-seq v1: 15285 STING-seq v2: 82339 beeSTING-seq: 39049 | Lentiviral | 10X Genomics 5′ seq | RNA + protein |
Epigenomics | ||||||||||
Perturb-ATAC [101] | GM12878, primary human keratinocytes | Barcode | CRISPRkoCRISPRi | Cas9 dCas9-KRAB | B cells: 40 keratinocytes: 7 | Yes | B cells: 2936 keratinocytes: 1356 | Lentiviral | Fluidigm C1 | Chromatin accessibility |
CRISPR-sciATAC [124] | HEK293FT, NIH/3T3, K562 | Poly-A | CRISPRko | Cas9 | Species mixing: 20 Chromatin modifiers: 66 Chromatin remodeling complexes: 255 | – | ~ 30000 | Lentiviral | Combinatorial indexing | Chromatin accessibility |
SPEAR-ATAC [125] | K562, GM12878, Mcf7 | gRNA-specific primer | CRISPRi | dCas9-KRAB | 414 | – | 104592 | Lentiviral | 10X Genomics ATAC-seq | Chromatin accessibility |